stock repurchase
ProPhase Labs to Repurchase $6M of Common Stock
The company plans to repurchase up to $6 million of its common shares over a six-month period, which the company's board will periodically reevaluate.
CareDx to Repurchase up to $50M of Common Stock
The company plans to purchase common shares through open market, privately negotiated, or other means for up to 24 months.
Prenetics Authorizes $20M Share Buyback
The Hong Kong-based diagnostics and genetic testing firm will repurchase up to $20 million of its class A ordinary shares during a two-year period.
Standard BioTools Authorizes $20M Share Buyback
The South San Francisco, California-based life science research tools provider authorized the repurchase of up to $20 million of shares of its common stock through Dec. 31, 2023.
QuidelOrtho Board Authorizes $300M Share Repurchase
The firm said it will repurchase up to $300 million in shares of common stock while also prioritizing R&D and manufacturing expansion.
Jan 22, 2020
4basebio Announces Treasury Share Buyback
May 10, 2019
Bruker Authorizes $300M Share Repurchase Program
May 6, 2019
Qiagen Q1 Revenues Grow 2 Percent
Nov 28, 2017
Bio-Rad Authorizes $250M Share Repurchase Program
Jan 18, 2017
Qiagen Details $250M Synthetic Share Repurchase Plan
Nov 13, 2015
Thermo Fisher Announces $1B Share Repurchase Plan
Nov 13, 2015
Bruker Board OKs $225M Share Repurchase Program
Nov 2, 2015
Illumina Launches $250M Share Repurchase Program
May 28, 2015
Agilent Board Approves $1.14B Share Buyback Program
May 22, 2015
Bruker Authorizes Share Buyback Program
May 13, 2015
Qiagen Repurchasing up to $30M of Shares
Feb 24, 2015
Myriad Board OKs $200M Share Repurchase Program
Sep 12, 2013